Jazz Pharmaceuticals (JAZZ) Interest & Investment Income (2010 - 2012)
Jazz Pharmaceuticals' (JAZZ) quarterly Interest & Investment Income came in at $71000.0 in Q1 2012, up 2.9% quarter-over-quarter from $69000.0 in Q4 2011.
Jazz Pharmaceuticals (JAZZ) Interest & Investment Income (2010 - 2012) Analysis & Trends
Jazz Pharmaceuticals' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $71000.0 for Q1 2012.
- On a quarterly basis, Interest & Investment Income changed N/A year-over-year to $71000.0 in Q1 2012; TTM through Mar 2012 was $146000.0, a N/A change from a year earlier, with the FY2011 full-year figure at $75000.0, up 1775.0% from the prior year.
- Interest & Investment Income grew to $71000.0 in Q1 2012 per JAZZ's latest filing, from $69000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $71000.0 in Q1 2012 and bottomed at -$3000.0 in Q3 2010.
- The 3-year median for Interest & Investment Income is $4000.0 (2010), against an average of $21142.9.
- Biggest YoY gain for Interest & Investment Income was 6800.0% in 2011; the steepest drop was 50.0% in 2011.
- Year by year, Interest & Investment Income stood at $1000.0 in 2010, then soared by 6800.0% to $69000.0 in 2011, then advanced by 2.9% to $71000.0 in 2012.
- Per Business Quant, the three latest JAZZ Interest & Investment Income figures stand at $71000.0 (Q1 2012), $69000.0 (Q4 2011), and $4000.0 (Q3 2011).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Jazz Pharmaceuticals | 15.81 Bn | 13.96 Bn | 934.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | 71,000.00 |
| Dec 31, 2011 | 69,000.00 |
| Sep 30, 2011 | 4,000.00 |
| Jun 30, 2011 | 2,000.00 |
| Dec 31, 2010 | 1,000.00 |
| Sep 30, 2010 | -3,000.00 |
| Jun 30, 2010 | 4,000.00 |